Condition

Cardiogenic Shock clinical trials and research

As of November 12, 2026, Find a Trial lists 72 Cardiogenic Shock clinical trials that are recruiting, at sites in 26 countries (most in United States (15), France (9), Italy (9)). 1 was first registered in the last 30 days. By phase: Phase 4 (4), Phase 2 (3), Phase 3 (2), Phase 2/3 (1). The most active sponsors are Tufts Medical Center (3), Samsung Medical Center (3), Universitätsklinikum Hamburg-Eppendorf (2). There are also 3 NIH-funded research projects on Cardiogenic Shock, with $2.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Cardiogenic Shock clinical trials

StudyPhaseWhereStatusRegistered
Factors Influencing Outcomes in ECMO and Impella Patients — Budapest Recruiting Oct 21, 2026
Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients — Weston, Florida Recruiting Sep 17, 2026
Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock — Beijing, Beijing Municipality Recruiting Aug 18, 2026
Left Ventricular Support and Advanced Monitoring in AMI–Cardiogenic Shock: Immediate Impella Use and PAC/Monitoring vs Standard Care — Leipzig, Saxony Recruiting Aug 13, 2026
CRP Apheresis for infarct-related cardiogenic shock — Leipzig, Saxony Recruiting Jul 7, 2026
Compare two ventilator modes in adults with cardiac ICU needs and invasive ventilation — Rochester, Minnesota Recruiting Jun 18, 2026
BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel — Basel, Canton of Basel-City Recruiting Jun 11, 2026
Optimizing Impella 5.5 Outcomes With Advanced Data Science — Vienna Recruiting Jun 1, 2026
Cardiogenic Shock Outcomes Registry (COR-SHOCK): how patients fare over time — Carnaxide, Lisbon District Recruiting May 19, 2026
Istaroxime for Stabilization in Acute Heart Failure with Cardiogenic Shock Phase 2/3 Yerevan Recruiting May 13, 2026

All recruiting trials (72)

NIH-funded research (3)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

Related topics

Heart FailureAcute Myocardial InfarctionAcute Myocardial Infarction (AMI)Acute Decompensated Heart FailureAcute Heart Failure (AHF)Extracorporeal Membrane OxygenationAcute Heart FailureCardiac Arrest (CA)Cardio Vascular DiseaseCardiogenic Shock Post Myocardial InfarctionCritical IllnessHemodynamic ManagementMechanical VentilationAcute Cardiovascular Disease

Quick answers

How many Cardiogenic Shock clinical trials are recruiting right now?

72, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 26 countries. The most sites are in United States (15 trials), France (9 trials), Italy (9 trials), Germany (8 trials), South Korea (6 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 4, Phase 2: 3, Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.